File(s) under embargo

7

month(s)

11

day(s)

until file(s) become available

Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?

journal contribution
posted on 23.06.2022, 10:51 by Robert ByrneRobert Byrne, Himanshu RaiHimanshu Rai, Roisin ColleranRoisin Colleran

Coronary artery disease (CAD) is a major cause of morbidity and mortality in patients with diabetes mellitus. In real-world registries of patients undergoing percutaneous coronary intervention (PCI), diabetic patients account for between 20 and 45% of treated of patients. Although improvements in preventive care for patients with diabetes in recent years has substantially reduced rates of cardiovascular complications, the incidence of acute myocardial infarction remains approximately five times higher in patients with versus those without diabetes mellitus.

Funding

Women As One

History

Comments

This is a pre-copyedited, author-produced PDF of an article accepted for publication in European Heart Journal following peer review. The version of record Byrne RA, Rai H, Colleran R. Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus? Eur Heart J. 2022;43(13):1331-1333 is available online at: https://doi.org/10.1093/eurheartj/ehab894

Published Citation

Byrne RA, Rai H, Colleran R. Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus? Eur Heart J. 2022;43(13):1331-1333

Publication Date

8 February 2022

PubMed ID

35137030

Department/Unit

  • School of Pharmacy and Biomolecular Sciences

Research Area

  • Population Health and Health Services
  • Vascular Biology

Publisher

Oxford University Press (OUP)

Version

  • Accepted Version (Postprint)